Sean Saint

Um, but what I will say is that, you know, I'm so proud of our team here because they do understand what it is that we're trying to do.

We're not trying to make the best technology possible.

We're trying to improve the user experience and everybody gets that.

Um, I think they got it when they came here, they got it when they interviewed and they get it when I evangelize it every day.

Um,

So, you know, look, you look at our chief product officer, Mike Menzinger.

I swear that guy's qualified to be my endocrinologist.

And obviously he's an engineer.

I mean, he gets how these things are used.

And, you know, right down to every engineer here really makes it their business to understand that.

So I hope it's it's been nothing but a positive.

We can all be advocates for the user experience.

Yeah.

So I'll probably hit our randomized clinical trial as well as some of our real world evidence here.

Fundamentally, we ran a trial where we had people come to us at a somewhat higher A1C.

A hemoglobin A1C is a measure of your average blood sugar over the last 90 days.

And it's sort of the gold standard measurement of how you're doing with your diabetes.

And ADA goal is 7.0.

Average in the country, I think, is about 8.3.

So we're not quite there yet.